The National Human Genome Research Institute (NHGRI) was established in 1989 with the primary mission to lead the National Institutes of Health (NIH) contribution to the Human Genome Project (HGP).
NPG speaks exclusively to Dr Robert Ruffolo, Jr.,Ph.D. President at Wyeth Research and Stephen Lederer, Senior Director at Pfizer about their current priorities in R&D including current focus areas, drivers and the role of new centres of excellence.
?Collaboration is essential for success. We need to collectively embark on an aggressive, well-coordinated research to create a new generation of performance standards and predictive tools for drug development.?
By Hartmut Juhl MD PhD, CEO of Indivumed GmbH, Center for Cancer Research at the Israelitisches Krankenhaus, Hamburg, Germany
On 20 October, Charles River Laboratories International, Inc. and Inveresk Research Group, Inc. officially merged under the Charles River Laboratories name